Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMCOpen access

Bio inspired assessment of titanium-organic framework and exosome-constructed p-Synephrine carriage: pursuing the PI3K/mTOR pathway in a simulated periodontitis

Kishta MS., Elshaar AH., Makled RN., Abdel-Aleem GA., Makled MN., Abdelhameed RM.

Laboratory Study on Chronic Inflammation, published in Sci Rep (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Sci Rep (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42185524
PMCID
PMC13201600
DOI
10.1038/s41598-026-54070-6

Abstract (original English)

Periodontitis, a chronic inflammatory disease, is driven by bacterial infection and oxidative stress, leading to tissue destruction and potential tooth loss. This study investigates the anti-inflammatory and antioxidant potential of p-Synephrine and enhanced delivery through NH 2- MIL-125 and exosomes derived from dental pulp stem cells (DPSCs). Primary Normal Human Gingival Keratinocytes (PCS) and Gingival Fibroblasts (HGF) were divided into eight groups, including controls, induction with LPS, and treatments with NH 2- MIL-125, exosomes, free p-Synephrine, p-Synephrine-loaded NH 2- MIL-125 (P-SYN-NH 2- MIL-125), p-Synephrine-loaded exosomes (P-SYN-Exo), and dexamethasone as a reference drug. Pro-inflammatory cytokines (IL-4, IL-6, TNF-α) and pathway markers (PI3K and mTOR) were quantified using ELISA kits, while antioxidant enzyme activities (GPx, SOD, and TAC) were assessed using colorimetric assays. Results showed that p-Synephrine loaded into NH 2- MIL-125 reduced inflammation markers and enhanced antioxidant defenses by increasingof GPx, SOD, and TAC concentrations. Among all treatments, p-Synephrine-loaded exosomes (P-SYN-Exo) demonstrated the most significant results, showing the highest increase in antioxidant markers GPx, SOD, and TAC, alongside a pronounced reduction in pro-inflammatory cytokines IL-4, IL-6, and TNF-α. Furthermore, p-Syn-Exo exhibited the most marked

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Cells, CulturedFibroblastsKeratinocytesStem CellsGingivaDental PulpHumansPeriodontitisTitaniumCytokines

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research